Ex-Dividend Date Aug 9, 2024 Beta -0.04 Short Interest N/A () Short Interest Change N/A Percent of Float N/A Advanced $ 5D Compare Chart Line chart with 402 data points. The chart has 1 X axis displaying Time. Range: 2025-01-14 06:59:45 to 2025-01-20 16:25:15. The chart ...
Calendar 2025-02-19 - Final dividend More about the company Quotes DatePriceChangeVolume 25-02-20 11,506.00 p -0.26% 149,403 25-02-19 11,704.00 p -0.71% 1,300,005 25-02-18 11,788.00 p +0.63% 1,256,095 25-02-17 11,714.00 p +0.05% 719,403 25-02-14 11,708.00 p...
Ex-Dividend Date Aug 8, 2024 Short Interest N/A % of Float Shorted N/A Average Volume 2.81M Performance 5 Day 1.74% 1 Month 7.30% 3 Month 0.23% YTD 7.30% 1 Year 6.97% Analyst Ratings Sell Under Hold Over Buy Number of Ratings 33 Full Ratings Recent News MarketWatch Dow ...
We remain committed to our ongoing Dato-DXd program in lung cancer and look forward to next year's readout for AVANZAR, the first phase 3 data for Dato-DXd in first-line lung cancer. And with that, please advance to the next slide and I'll pass over to Ruud to cover BioPharmaceuticals...
Thank you, Andy. Welcome everybody. It's great to see you all here today. Next slide please. 2024 was a very strong year for our company, I would say a very, very amazing year, I have to say, with total revenue up 21% and a core EPS up 19% as you can see here, a clear ...
Dividend$1.03 Ex-Dividend DateFeb 21, 2025 Short Interest15.46M02/14/25 % of Float Shorted0.50% Average Volume5.49M Recent News AstraZeneca: Camizestrant Improved PFS in 1L HR+ Breast Cancer Feb. 26, 2025 at 2:40 a.m. ET AstraZeneca Sales, Core EPS Seen Rising -- Earnings Preview ...
Average Volume (3M)2.64M Market Cap £161.79B Enterprise Value179.97B Total Cash (Recent Filing)$5.84B Total Debt (Recent Filing)$28.62B Price to Earnings (P/E)31.6 Beta0.97 Next Earnings Feb 06, 2025 EPS Estimate £1.7 Last Dividend Ex-Date ...
More than 1.46 million boosters administered to date with 250,000 receiving a jab this week Sat Dec 18 2021 - 13:31 Covid: Numbers in hospital to reach between 650 and 2,000 next month, Nphet says Surge in Omicron cases to see ‘even greater’ impact on ICU with numbers exceeding 200...
ETFs can greatly simplify cryptocurrency exposure for novice and experienced investors alike. Tony Dong andBrady Porche Feb. 12, 2025 Investing 10 of the Best Stocks to Buy for 2025 Analysts have good reasons to be optimistic about each of the following stocks. ...
Thank you very much, Marc. Please move to the next slide. Together with the Board I’m pleased to announce Michel Demare will take over from Leif Johansson as Chair following the 2023 AGM. I have worked closely with Michel since he joined our Board in 2019. And I look forward to our ...